Le Lézard
Classified in: Health, Business
Subject: CXP

Coverage Expansion Continues for One- and Two-level Lumbar Total Disc Replacement as the Top Commercial Payer in Tennessee Establishes Positive Coverage for Centinel Spine's prodisc® L


WEST CHESTER, Pa., Feb. 21, 2024 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced significant expansion of coverage for lumbar TDR procedures in Tennessee.

The policy expansion announced by Tennessee's largest commercial payer?effective March 1, 2024?represents over 2.3 million covered lives across the state and includes a positive coverage recommendation for both one- and two-level lumbar TDR. Because prodisc L is the only lumbar TDR device with FDA approval for two-level use, the two-level coverage recommendation only applies to the use of the prodisc L lumbar device.

This major positive coverage update continues the trend toward significant coverage for one- and two-level lumbar TDR. In August 2023, the largest payers in Illinois, New Mexico, Oklahoma, and Texas?representing over 16 million covered lives?adopted Carelon's Clinical Appropriateness Guidelines-Musculoskeletal Spine Surgery Criteria, which deems one- and two-level lumbar TDR medically necessary. In September 2023, the largest commercial payer in Michigan added one- and two-level lumbar TDR coverage, providing 5.7 million covered lives with access to lumbar TDR. Then, in October 2023, the largest commercial payer in North Carolina adopted Carelon's Clinical Appropriateness Guidelines-Musculoskeletal Spine Surgery Criteria for lumbar TDR, as well?adding another 2.8 million covered lives.

With this favorable coverage expansion in Tennessee, it is estimated that coverage for one-level lumbar TDR has grown from 50% of covered lives in 2017 to now approaching 94%* today?and that over 30% of commercially-covered lives in the U.S. now have access to two-level lumbar TDR, as well.

Centinel Spine CEO Steve Murray shared, "The top commercial payer in Tennessee has now provided much needed one- and two-level lumbar total disc replacement access to a significant number of individuals. We have seen an acceleration of positive lumbar disc replacement coverage over the last 6 months. This is good for patients, and we believe this trend will continue as other payers recognize the clear and published clinical benefits of the total disc replacement procedure."

* Data of file, estimate based on combined positive and neutral policies.

About Centinel Spine, LLC

Centinel Spine®, LLC is the leading global medical device company exclusively focused on addressing cervical and lumbar spinal disease with prodisc®, the most complete total disc replacement (TDR) technology platform in the world.

The Company's prodisc technology is the most studied and clinically-proven TDR system across the globe, validated by over 540 published papers and more than 250,000 implantations. Centinel Spine's prodisc is the only TDR technology with multiple motion-preserving anatomic solutions, allowing the surgeon to Match-the-Disctm to each patient's anatomy for both cervical and lumbar total disc replacement.

For more information, please visit the company's website at www.CentinelSpine.com or contact:

Varun Gandhi
Chief Financial Officer
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: [email protected] 

SOURCE Centinel Spine, LLC


These press releases may also interest you

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...



News published on and distributed by: